You just read:

New SEER registry "big data" demonstrates the Oncotype DX® test accurately predicts clinical breast cancer outcomes, bringing the total number of patients in prospective outcome studies to 50,000

News provided by

Genomic Health, Inc.

14 Dec, 2015, 08:00 GMT